ArticleHematology. American Society of Hematology. Education Program2023
Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores.
Jacob Rozmus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it